Chen H-X, Wang W, Xiao H-Q, Wang H, Ding X-D
Department of Rehabilitation, Xiangyang Hospital Affiliated to Hubei University of Medicine, Xiangyang, Hubei Province, China.
Eur Rev Med Pharmacol Sci. 2015;19(9):1696-9.
To evaluate the clinical efficacy under ultrasound-guided injection of botulinum toxin-A (BTX-A) and EMG biofeedback treatment of the lower limb muscle spasm after cerebral infarction.
Thirty-six cases of lower limb muscle spasm after cerebral infarction hemiplegia were randomly divided into two groups, the treatment group and the control group respectively including 18 cases. Both groups of patients were injected with BTX-A at different sites on spastic muscles. Twenty-four hours later, the treatment group was administered EMG biofeedback. Then, the modified Ashworth scoring was employed to observe the curative effect of the two groups.
After six weeks' injection, the treatment group scored better than the control group (p < 0.05).
Ultrasound-guided injection of botulinum toxin type A at various sites with EMG biofeedback treatment of the lower limb muscle spasms after cerebral infarction is efficient and conducive to the rehabilitation of patients' motor functions.
评估超声引导下注射A型肉毒毒素(BTX-A)联合肌电图生物反馈治疗脑梗死所致下肢肌肉痉挛的临床疗效。
将36例脑梗死偏瘫后下肢肌肉痉挛患者随机分为两组,治疗组和对照组各18例。两组患者均在痉挛肌肉的不同部位注射BTX-A。24小时后,治疗组接受肌电图生物反馈治疗。然后,采用改良Ashworth评分法观察两组的疗效。
注射六周后,治疗组评分优于对照组(p<0.05)。
超声引导下在不同部位注射A型肉毒毒素联合肌电图生物反馈治疗脑梗死所致下肢肌肉痉挛疗效显著,有利于患者运动功能的康复。